Profil
Rutger Tulleken is the founder of AMT Medical BV.
He held the title of Chief Executive Officer at the company.
Aktive Positionen von Rutger Tulleken
| Unternehmen | Position | Beginn |
|---|---|---|
AMT Medical BV
 AMT Medical BV Medical SpecialtiesHealth Technology AMT Medical BV is a clinical stage medical device company based in Ede, Netherlands, that is developing a highly innovative and unique heart bypass system. The Elana heart bypass solution is designed to perform bypass surgery through small holes in the chest, without the need for open-heart surgery, split ribcage, heart-lung machine, or sutures. The innovative Elana procedure is applicable both in open chest and totally endoscopic procedure settings. The Dutch company collaborates with the UMC Utrecht, the St. Antonius Hospital Nieuwegein, and the German Heart Center/Charité in Berlin to develop a new improved way of performing heart bypasses. The company aims to improve the quality of life of millions of patients and their loved ones by minimizing long recovery times and serious complications. The company was founded by Rutger Tulleken, who has been the CEO since incorporation. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
AMT Medical BV
AMT Medical BV Medical SpecialtiesHealth Technology AMT Medical BV is a clinical stage medical device company based in Ede, Netherlands, that is developing a highly innovative and unique heart bypass system. The Elana heart bypass solution is designed to perform bypass surgery through small holes in the chest, without the need for open-heart surgery, split ribcage, heart-lung machine, or sutures. The innovative Elana procedure is applicable both in open chest and totally endoscopic procedure settings. The Dutch company collaborates with the UMC Utrecht, the St. Antonius Hospital Nieuwegein, and the German Heart Center/Charité in Berlin to develop a new improved way of performing heart bypasses. The company aims to improve the quality of life of millions of patients and their loved ones by minimizing long recovery times and serious complications. The company was founded by Rutger Tulleken, who has been the CEO since incorporation. | Health Technology |
